CALGARY, Alberta, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Company") (TSX:RVX, Financial) announces that it has postponed the webcast and conference call, previously scheduled for January 28th, 2021, by one week to February 4th, 2021 at 10:00 am MT. This will allow the Company to provide the most up-to-date and accurate information regarding the BETonMACE2 trial design and launch, COVID-19 research and clinical plan and update on financing.
Resverlogix Reschedules Update Webcast and Conference Call
